1Manuel SM, John M. Chylothorax: Diagnosis and management in children. Paediatric Respiratory Review,2009,10 (4) : 199-207.
2Anderst J. Chylothorax and child abuse. Pediatr Crit Care Med, 2007,8 ( 4 ) : 394 -396.
3Agrawal V, Sahn SA. Lipid pleural effusions. Am J Med Sci, 2008,335 ( 1 ) : 16-20.
4Shah D, Sinn JK. Octreotide as therapeutic option tor congenital idiopathic chylothorax: a case report. Acta Paediatr, 2012, 101 (4) :e151-155.
5White SC, Seckeler MD, McCulloch MA, et al. Patients with single ventricle anatomy may respond better to octreotide therapy for chylothorax after congenital heart surgery. J Card Surg,2014,29 (2) :259-264.
6Swenne I, Rosling A. Omega-3 essential fatty acid status is im- proved during nutritional rehabilitation of adolescent girls with eating disorders and weight loss. Acta Paediatr, 2012,101 (8) : 858-861.
7Bistrian BR. Clinical aspects of essential iatty acid metabolism: Jonathan Rhoads Lecture. JPEN ,2003,27 ( 3 ) : 168-175.
8Biewer ES, Ztim C, Arnold R, et al. Chylothorax after surgery on congenital heart disease in newborns and infants-risk factors and efficacy of MCT-diet. Journal of Cardiothoracic Surgery,2010,5 : 127-133.
2Baiocchi G, Faloppa CC, Araujo RL, et al. Chylous ascites in gy- necologic malignancies: cases report and literature review. Arch Gynecol Obstet,2010,281 (4) :677-681.
3Zhou DX, Zhou HB, Wang Q, et al. The conservative treatment of postoperative chylous ascites in gynecologic cancers:four case re- ports. Arch Gynecol Obstet,2012,285 ( 3 ) :849-851.
4Han D, Wu X, Li J, et al. Postoperative chylous ascites in patients with gynecologic malignancies. Int J Gynecol Cancer, 2012,22 (2) :186-190.
